title: [Is a different view on the pathophysiology of sepsis the key for novel therapeutic options?].
abstract: Sepsis remains a critical problem in virtually all fields of clinical medicine. Despite intensive scientific and clinical efforts no significant progress has emerged in the fight against sepsis mortality. Solely the algorithm of the "surviving sepsis campaign" has proven to result in significantly enhanced survival of sepsis patients when consequently adopted. Novel research in the field of the complex immunological alterations in sepsis suggests that ongoing immunosuppression is the critical determinant underlying sepsis mortality. Therefore, it was proposed that immunostimulation might be a successful approach to improve outcome in individually selected patients. Others favor a different view on the pathophysiology of sepsis and support the notion that the manifestation of organ failure may be the dominant therapeutic target. Due to the fact that breakdown of the microcirculation and disruption of the microvascular barrier are critical events preceding organ failure, experimental therapeutic efforts to address these events led to promising results. Taken together, in view of the many initially promising experimental data and the failure to translate them into successful clinical therapies, a different view on the pathophysiology of sepsis is warranted to obtain the key for novel therapeutic options.
authors.affiliation: Klinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie, AG Inflammation und Sepsis, Universitätsklinik Würzburg, Oberdürrbacherstr. 6, 97080, Würzburg, Deutschland, Schlegel_N@ukw.de.
authors.forename: N
authors.initials: N
authors.lastname: Schlegel
authors.forename: S
authors.initials: S
authors.lastname: Flemming
authors.forename: M
authors.initials: M
authors.lastname: Meir
authors.forename: C-T
authors.initials: CT
authors.lastname: Germer
mesh_terms: D000465:Algorithms; D019559:Capillary Leak Syndrome / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D004211:Disseminated Intravascular Coagulation / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D061345:Early Medical Intervention; D006474:Hemorrhagic Disorders / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance / Q000502:physiology; D007114:Immunization / Q000379:methods; D009102:Multiple Organ Failure / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D018805:Sepsis / Q000401:mortality / Q000503:physiopathology* / Q000628:therapy; D012772:Shock, Septic / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D015996:Survival Rate
references.citation: Trends Mol Med. 2014 Apr;20(4):195-203
references.pmid: 24581450
references.citation: Chest. 1997 Jul;112(1):235-43
references.pmid: 9228382
references.citation: Semin Respir Crit Care Med. 2012 Jun;33(3):257-65
references.pmid: 22718211
references.citation: Crit Care Med. 2009 May;37(5):1735-43
references.pmid: 19325485
references.citation: N Engl J Med. 2013 Aug 29;369(9):840-51
references.pmid: 23984731
references.citation: N Engl J Med. 2012 May 31;366(22):2055-64
references.pmid: 22616830
references.citation: Anesth Analg. 2009 Jun;108(6):1841-7
references.pmid: 19448210
references.citation: Lancet. 1998 Mar 28;351(9107):950-3
references.pmid: 9734942
references.citation: Ger Med Sci. 2010 Jun 28;8:Doc14
references.pmid: 20628653
references.citation: JAMA. 2011 Dec 21;306(23):2594-605
references.pmid: 22187279
references.citation: Blood. 2011 Jan 27;117(4):1205-17
references.pmid: 20956800
references.citation: J Exp Med. 2008 Jun 9;205(6):1303-15
references.pmid: 18474628
references.citation: Sci Transl Med. 2011 Jun 22;3(88):88ps25
references.pmid: 21697528
references.citation: Lancet Infect Dis. 2013 Mar;13(3):260-8
references.pmid: 23427891
references.citation: N Engl J Med. 2006 Jun 15;354(24):2564-75
references.pmid: 16714767
references.citation: Nat Rev Immunol. 2013 Dec;13(12):862-74
references.pmid: 24232462
references.citation: J Physiol. 2012 Jun 1;590(11):2693-708
references.pmid: 22495586
references.citation: N Engl J Med. 2010 Aug 12;363(7):689-91
references.pmid: 20818861
references.citation: Sci Transl Med. 2010 Mar 17;2(23):23ra19
references.pmid: 20375003
references.citation: Crit Care Med. 2011 Feb;39(2):259-65
references.pmid: 20975548
references.citation: Shock. 2014 Jun;41(6):537-45
references.pmid: 24569506
references.citation: Crit Care Med. 2013 Feb;41(2):580-637
references.pmid: 23353941
references.citation: Semin Thromb Hemost. 2013 Jul;39(5):559-66
references.pmid: 23625756
references.citation: Am J Respir Crit Care Med. 2009 Oct 1;180(7):640-8
references.pmid: 19590022
references.citation: Cardiovasc Res. 2010 Jul 15;87(2):243-53
references.pmid: 20299335
references.citation: Am J Respir Crit Care Med. 2012 Jan 1;185(1):110-2
references.pmid: 22210794
references.citation: J Exp Med. 2011 Dec 19;208(13):2581-90
references.pmid: 22110166
references.citation: Crit Care Med. 1992 Jun;20(6):864-74
references.pmid: 1597042
references.citation: Am J Physiol Lung Cell Mol Physiol. 2013 Oct 1;305(7):L455-66
references.pmid: 23911436
references.citation: Cell Tissue Res. 2014 Mar;355(3):587-96
references.pmid: 24322391
references.citation: Virulence. 2014 Jan 1;5(1):73-9
references.pmid: 24067428